151 related articles for article (PubMed ID: 8813371)
1. Inhibitory effects of diltiazem, an L-type Ca2+ channel blocker, on naloxone-increased glutamate levels in the locus coeruleus of opioid-dependent rats.
Tokuyama S; Ho IK
Brain Res; 1996 May; 722(1-2):212-6. PubMed ID: 8813371
[TBL] [Abstract][Full Text] [Related]
2. The role of glutamate in the locus coeruleus during opioid withdrawal and effects of H-7, a protein kinase inhibitor, on the action of glutamate in rats.
Tokuyama S; Zhu H; Wakabayashi H; Feng YZ; Ho IK
J Biomed Sci; 1998; 5(1):45-53. PubMed ID: 9570513
[TBL] [Abstract][Full Text] [Related]
3. Effects of diltiazem, a Ca2+ channel blocker, on naloxone-precipitated changes in dopamine and its metabolites in the brains of opioid-dependent rats.
Tokuyama S; Ho IK
Psychopharmacology (Berl); 1996 May; 125(2):135-40. PubMed ID: 8783387
[TBL] [Abstract][Full Text] [Related]
4. Ca2+ channel blocker, diltiazem, prevents physical dependence and the enhancement of protein kinase C activity by opioid infusion in rats.
Tokuyama S; Feng Y; Wakabayashi H; Ho IK
Eur J Pharmacol; 1995 Jun; 279(1):93-8. PubMed ID: 7556388
[TBL] [Abstract][Full Text] [Related]
5. Increased locus coeruleus glutamate levels are associated with naloxone-precipitated withdrawal from butorphanol in the rat.
Feng YZ; Zhang T; Rockhold RW; Ho IK
Neurochem Res; 1995 Jun; 20(6):745-51. PubMed ID: 7566372
[TBL] [Abstract][Full Text] [Related]
6. Precipitated kappa-opioid receptor agonist withdrawal increase glutamate in rat locus coeruleus.
Hoshi K; Ma T; Ho IK
Eur J Pharmacol; 1996 Oct; 314(3):301-6. PubMed ID: 8957250
[TBL] [Abstract][Full Text] [Related]
7. Further evidence for a role of NMDA receptors in the locus coeruleus in the expression of withdrawal syndrome from opioids.
Tokuyama S; Zhu H; Oh S; Ho IK; Yamamoto T
Neurochem Int; 2001 Aug; 39(2):103-9. PubMed ID: 11408088
[TBL] [Abstract][Full Text] [Related]
8. Mu- and delta-opioid receptor antagonists precipitate similar withdrawal phenomena in butorphanol and morphine dependence.
Feng YZ; Zhang T; Tokuyama S; Zhu H; Rockhold RW; Ho IK
Neurochem Res; 1996 Jan; 21(1):63-71. PubMed ID: 8833225
[TBL] [Abstract][Full Text] [Related]
9. Nor-binaltorphimine precipitates withdrawal and excitatory amino acid release in the locus ceruleus of butorphanol--but not morphine-dependent rats.
Feng Y; Rockhold RW; Ho IK
J Pharmacol Exp Ther; 1997 Nov; 283(2):932-8. PubMed ID: 9353416
[TBL] [Abstract][Full Text] [Related]
10. Increased release of excitatory amino acids in rat locus coeruleus in kappa-opioid agonist dependent rats precipitated by nor-binaltorphimine.
Hoshi K; Ma T; Oh S; Ho IK
Brain Res; 1997 Apr; 753(1):63-8. PubMed ID: 9125432
[TBL] [Abstract][Full Text] [Related]
11. Excitatory amino acid release in the locus coeruleus during naloxone-precipitated morphine withdrawal in adjuvant arthritic rats.
Hoshi K; Yamamoto A; Ishizuki S; Fujihira E; Ichihara K
Inflamm Res; 2000 Jan; 49(1):36-41. PubMed ID: 10778919
[TBL] [Abstract][Full Text] [Related]
12. Possible involvement of protein kinases in physical dependence on opioids: studies using protein kinase inhibitors, H-7 and H-8.
Tokuyama S; Feng Y; Wakabayashi H; Ho IK
Eur J Pharmacol; 1995 Sep; 284(1-2):101-7. PubMed ID: 8549612
[TBL] [Abstract][Full Text] [Related]
13. Direct evidence for a role of glutamate in the expression of the opioid withdrawal syndrome.
Tokuyama S; Wakabayashi H; Ho IK
Eur J Pharmacol; 1996 Jan; 295(2-3):123-9. PubMed ID: 8720575
[TBL] [Abstract][Full Text] [Related]
14. Diltiazem inhibits naloxone-precipitated and spontaneous morphine withdrawal in rats.
Kishioka S; Inoue N; Nishida S; Fukunaga Y; Yamamoto H
Eur J Pharmacol; 1996 Nov; 316(1):7-14. PubMed ID: 8982643
[TBL] [Abstract][Full Text] [Related]
15. Withdrawal from dependence upon butorphanol uniquely increases kappa(1)-opioid receptor binding in the rat brain.
Fan LW; Tanaka S; Tien LT; Ma T; Rockhold RW; Ho IK
Brain Res Bull; 2002 Jun; 58(2):149-60. PubMed ID: 12127012
[TBL] [Abstract][Full Text] [Related]
16. Naloxone-precipitated changes in biogenic amines and their metabolites in various brain regions of butorphanol-dependent rats.
Tokuyama S; Wakabayashi H; Hoskins B; Ho IK
Pharmacol Biochem Behav; 1996 Jun; 54(2):461-8. PubMed ID: 8743609
[TBL] [Abstract][Full Text] [Related]
17. Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis.
Sinchaisuk S; Ho IK; Rockhold RW
Pharmacol Biochem Behav; 2002 Dec; 74(1):241-52. PubMed ID: 12376173
[TBL] [Abstract][Full Text] [Related]
18. Suppression of acute and chronic opioid withdrawal by a selective soluble guanylyl cyclase inhibitor.
Sullivan ME; Hall SR; Milne B; Jhamandas K
Brain Res; 2000 Mar; 859(1):45-56. PubMed ID: 10720614
[TBL] [Abstract][Full Text] [Related]
19. Naloxone-precipitated morphine withdrawal increases pontine glutamate levels in the rat.
Zhang T; Feng Y; Rockhold RW; Ho IK
Life Sci; 1994; 55(2):PL25-31. PubMed ID: 7912397
[TBL] [Abstract][Full Text] [Related]
20. Noradrenaline release in rat locus coeruleus is regulated by both opioid and alpha(2) -adrenoceptors.
Nakai T; Hayashi M; Ichihara K; Wakabayashi H; Hoshi K
Pharmacol Res; 2002 May; 45(5):407-12. PubMed ID: 12123629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
